Developer docs
API playgroundTry for free, no card

Search company profiles

Actum Pharma

Full company profile

uuid000jz9g

Namestring
Actum Pharma
Legal namestring
Actum Pharma
Websiteurl
actumpharma.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Actum Pharma is a privately held consulting and operating partner services firm founded in 2024 and headquartered in Berwyn, Pennsylvania. The company is purpose-built for rare disease, orphan drug, and complex condition biopharma manufacturers, deploying experienced operators alongside client teams from clinical stages through commercial launch. Rather than operating as a traditional consultancy pushing fixed service packages, Actum functions as a flexible, financially-minded operating partner that fills specific expertise and execution gaps in capital strategy, commercialization planning, and patient services for small-population therapies. The firm's target buyers are small, founder-led clinical-stage biopharma manufacturers, their investors, and strategic partners who need rare-disease-specific commercial guidance that standard blockbuster-drug playbooks do not address.

The company's service offering is organized into three interconnected phases—FUND (Capital Strategy for fundraising and cash runway management, including contingency planning for regulatory setbacks), PLAN (Commercialization Planning and Patient-Product Journey Mapping, including market analysis, HCP strategy, and payer frameworks designed for specific diseases), and MARKET (Distribution & Patient Services, including specialty pharmacy selection, branded HUB programs, benefits investigation, prior authorization, copay assistance, and adherence support). Differentiation rests on rare disease domain specialization, engagement from clinical stage and earlier, and an integrated approach across funding, commercial planning, and distribution. The firm has supported engagements including an Expanded Access Program for a clinical-stage rare skin condition company navigating a Phase 3 setback and a branded HUB program for a first-time cell and gene therapy manufacturer.

Actum's go-to-market combines direct consultative sales to biopharma C-suite leaders, functional business leads, and investors with a consortium partner model that includes Preferred and Standard Partners offering referrals, co-marketing, and multi-partner proposals. Revenue is generated through professional services on a quote-based engagement model, with pricing not publicly disclosed. The company has 1-10 employees, serves a global clientele from its U.S. base, and builds category authority through conference appearances, co-branded webinars, whitepapers, and earned media features in BioXconomy, pharmaphorum, and BioProcess International.

Short descriptiontext

Actum Pharma is a Berwyn, PA-based operating partner firm founded in 2024 that provides consulting and commercialization services to clinical-stage biopharma manufacturers developing rare disease and orphan drug therapies, integrating capital strategy, patient journey mapping, and HUB-based distribution design.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBerwyn, United States
HQ citystring
Berwyn
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease commercialization, orphan drug consulting, biopharma operating partner, patient services HUB programs, biopharma commercialization planning
Industry1 code
1Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
CodeHLAGAAALPrimaryYes
NAICS code1 code
  • Marketing Consulting Services541613
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Biopharma Consulting Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Consulting and Advisory Services
TypeProfessional Services
Description

Actum Pharma provides consulting and operating partner services to biopharma companies. The company operates as a flexible partner model, offering modular, gap-filling support across capital strategy, commercialization planning, and launch execution.

actumpharma.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Actum Pharma provides consulting and operating partner services to clinical-stage biopharma companies developing rare disease, orphan drug, and complex-condition therapies. The firm deploys experienced operators alongside client teams from clinical stage through commercial launch, delivering modular, gap-filling support across capital strategy, rare-disease-specific commercialization planning, patient-product journey mapping, fit-for-purpose distribution design, and patient-first branded HUB programs.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Actum Pharma is a consulting and operating partner services firm, not a software product company. They provide a unified service offering organized into three interconnected phases: FUND (Capital Strategy for fundraising and cash runway management), PLAN (Commercialization Planning and Patient-Product Journey Mapping), and MARKET (Distribution & Patient Services including SP selection, branded HUB programs, benefits investigation, prior authorization, copay assistance, and adherence support). Their model is modular and gap-filling, designed to support rare disease, orphan drug, and complex condition therapies from clinical stage through commercial launch.

Product and service3 records
1FUND - Capital Strategy for Rare Disease
2PLAN - Rare Disease Commercialization Planning and Patient-Product Journey Mapping
3MARKET - Distribution Design and Patient Services (HUB Programs)
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierStandardTypeStrategic or Co-development Partner
Strategic tierPreferredTypeStrategic or Co-development Partner
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Actum Pharma

Biopharma Consulting Servicesactumpharma.com

Actum Pharma is a Berwyn, PA-based operating partner firm founded in 2024 that provides consulting and commercialization services to clinical-stage biopharma manufacturers developing rare disease and orphan drug therapies, integrating capital strategy, patient journey mapping, and HUB-based distribution design.

What Actum Pharma does

Actum Pharma is a privately held consulting and operating partner services firm founded in 2024 and headquartered in Berwyn, Pennsylvania. The company is purpose-built for rare disease, orphan drug, and complex condition biopharma manufacturers, deploying experienced operators alongside client teams from clinical stages through commercial launch. Rather than operating as a traditional consultancy pushing fixed service packages, Actum functions as a flexible, financially-minded operating partner that fills specific expertise and execution gaps in capital strategy, commercialization planning, and patient services for small-population therapies. The firm's target buyers are small, founder-led clinical-stage biopharma manufacturers, their investors, and strategic partners who need rare-disease-specific commercial guidance that standard blockbuster-drug playbooks do not address.

The company's service offering is organized into three interconnected phases—FUND (Capital Strategy for fundraising and cash runway management, including contingency planning for regulatory setbacks), PLAN (Commercialization Planning and Patient-Product Journey Mapping, including market analysis, HCP strategy, and payer frameworks designed for specific diseases), and MARKET (Distribution & Patient Services, including specialty pharmacy selection, branded HUB programs, benefits investigation, prior authorization, copay assistance, and adherence support). Differentiation rests on rare disease domain specialization, engagement from clinical stage and earlier, and an integrated approach across funding, commercial planning, and distribution. The firm has supported engagements including an Expanded Access Program for a clinical-stage rare skin condition company navigating a Phase 3 setback and a branded HUB program for a first-time cell and gene therapy manufacturer.

Actum's go-to-market combines direct consultative sales to biopharma C-suite leaders, functional business leads, and investors with a consortium partner model that includes Preferred and Standard Partners offering referrals, co-marketing, and multi-partner proposals. Revenue is generated through professional services on a quote-based engagement model, with pricing not publicly disclosed. The company has 1-10 employees, serves a global clientele from its U.S. base, and builds category authority through conference appearances, co-branded webinars, whitepapers, and earned media features in BioXconomy, pharmaphorum, and BioProcess International.

Actum Pharma firmographics

Firmographics
Name
Actum Pharma
Legal name
Actum Pharma
Website
https://actumpharma.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
Actum Pharma is a Berwyn, PA-based operating partner firm founded in 2024 that provides consulting and commercialization services to clinical-stage biopharma manufacturers developing rare disease and orphan drug therapies, integrating capital strategy, patient journey mapping, and HUB-based distribution design.
Ownership category
akta.pro rank

Actum Pharma industry classification

Industry
Product category
Biopharma Consulting Services
NAICS
Marketing Consulting Services (541613)
SIC
Services-Management Consulting Services (8742)
akta.pro primary industry
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

  • Rare disease commercialization
  • Orphan drug consulting
  • Biopharma operating partner
  • Patient services HUB programs
  • Biopharma commercialization planning

Where Actum Pharma is headquartered

Location

Headquarters

HQ city
Berwyn
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Actum Pharma business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Consulting and Advisory Services: Actum Pharma provides consulting and operating partner services to biopharma companies. The company operates as a flexible partner model, offering modular, gap-filling support across capital strategy, commercialization planning, and launch execution.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Actum Pharma product offering

Product offering

Core offering

Actum Pharma provides consulting and operating partner services to clinical-stage biopharma companies developing rare disease, orphan drug, and complex-condition therapies. The firm deploys experienced operators alongside client teams from clinical stage through commercial launch, delivering modular, gap-filling support across capital strategy, rare-disease-specific commercialization planning, patient-product journey mapping, fit-for-purpose distribution design, and patient-first branded HUB programs.

Product overview

Actum Pharma is a consulting and operating partner services firm, not a software product company. They provide a unified service offering organized into three interconnected phases: FUND (Capital Strategy for fundraising and cash runway management), PLAN (Commercialization Planning and Patient-Product Journey Mapping), and MARKET (Distribution & Patient Services including SP selection, branded HUB programs, benefits investigation, prior authorization, copay assistance, and adherence support). Their model is modular and gap-filling, designed to support rare disease, orphan drug, and complex condition therapies from clinical stage through commercial launch.

Differentiator

Problem solved

Functional benefit

Products and services

  • FUND - Capital Strategy for Rare Disease
  • PLAN - Rare Disease Commercialization Planning and Patient-Product Journey Mapping
  • MARKET - Distribution Design and Patient Services (HUB Programs)

Companies that use Actum Pharma

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Actum Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Actum Pharma partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered standard and preferred.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Actum Pharma competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key highlights6 records

Customer concentration

Actum Pharma social profiles

Digital presence

Actum Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Actum Pharma leadership team

Management profile

Number of profiles

Actum Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Actum Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Actum Pharma

What does Actum Pharma do?

Actum Pharma provides consulting and operating partner services to clinical-stage biopharma companies developing rare disease, orphan drug, and complex-condition therapies. The firm deploys experienced operators alongside client teams from clinical stage through commercial launch, delivering modular, gap-filling support across capital strategy, rare-disease-specific commercialization planning, patient-product journey mapping, fit-for-purpose distribution design, and patient-first branded HUB programs.

Is Actum Pharma a public or private company?

Actum Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Actum Pharma founded?

Actum Pharma was founded in 2024. It employs 1 to 10 people.

Where is Actum Pharma based?

Actum Pharma is headquartered in Berwyn, United States, in the North America region.

How does Actum Pharma make money?

One revenue line is on record: consulting and Advisory Services.

Does Actum Pharma have an API?

No public API is recorded for Actum Pharma.

What industry is Actum Pharma in?

Actum Pharma's product category is Biopharma Consulting Services. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 541613 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales